跳至主要内容
临床试验/NCT04803266
NCT04803266Unknown3 期

Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer: a Randomized, Phase 3 Trial

Yonsei University1 个研究点 分布在 1 个国家目标入组 747 人开始时间: 2008年11月5日最近更新:
适应症

试验速览

阶段
3 期
入组人数
747
试验地点
1
主要终点
Disease-free survival

研究概览

简要总结

The aim of this study is to find out whether the inclusion of internal mammary node irradiation in regional nodal irradiation improves outcomes in women with node-positive breast cancer.

详细描述

This is a multicenter, prospective, randomized phase 3 trial. Patients with node-positive breast cancer without distant metastases were included. All patients underwent breast conservation surgery or mastectomy with axillary lymph node dissection before irradiation. Patients underwent regional nodal irradiation along with breast or chest wall irradiation and randomly allocated to either IMNI or no IMNI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with histologically confirmed node-positive breast cancer who had undergone modified radical mastectomy or breast-conserving surgery and axillary dissection with ≥8 nodes removed.

排除标准

  • Neoadjuvant chemotherapy
  • Bilateral breast cancer
  • Distant metastasis
  • History of other malignancy
  • Involvement of supraclavicular nodes or internal mammary nodes at diagnosis

结局指标

主要结局

Disease-free survival

时间窗: 7 years

次要结局

  • breast cancer-specific survival(7 years)
  • Number of patients with treatment-related toxicities as assessed by RTOG/EORTC Toxicity criteria and NCI CTCAE v3(7 years)
  • Rates of overall survival(7 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验